ABBADESSA, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 895
NA - Nord America 520
AS - Asia 143
Totale 1.558
Nazione #
US - Stati Uniti d'America 518
IT - Italia 435
IE - Irlanda 142
CN - Cina 78
FR - Francia 63
DE - Germania 59
GB - Regno Unito 56
UA - Ucraina 55
SG - Singapore 34
SE - Svezia 28
TR - Turchia 24
FI - Finlandia 23
BE - Belgio 13
GR - Grecia 9
NL - Olanda 9
KR - Corea 3
CH - Svizzera 2
MX - Messico 2
CZ - Repubblica Ceca 1
IN - India 1
JP - Giappone 1
PK - Pakistan 1
TW - Taiwan 1
Totale 1.558
Città #
Dublin 142
Chandler 91
Jacksonville 83
Ann Arbor 61
Rome 39
Caserta 35
Milan 32
Santa Clara 32
Singapore 31
Nanjing 23
Cambridge 21
Düsseldorf 21
Woodbridge 20
Naples 16
Beijing 14
Boardman 14
Bremen 14
Princeton 14
Kocaeli 13
Brussels 12
Bari 11
Medford 11
San Mateo 9
Guangzhou 8
Helsinki 8
New York 8
Wilmington 8
Cerami 7
Bologna 6
Kunming 6
Palermo 6
Roxbury 6
Auburn Hills 5
Catania 5
Lanzhou 5
Angri 4
Des Moines 4
Ferrara 4
Rockville 4
Ashburn 3
Bergamo 3
City of Westminster 3
Genoa 3
Napoli 3
Pontecagnano 3
Seoul 3
Shenyang 3
Ancona 2
Barano d'Ischia 2
Bassano del Grappa 2
Bonefro 2
Campagnano di Roma 2
Castellammare Di Stabia 2
Cesena 2
Cittanova 2
Conselve 2
Crema 2
Crispano 2
Deiva Marina 2
Dresano 2
Enna 2
Gavardo 2
Haikou 2
Houston 2
Jinan 2
Lecce 2
Legnaro 2
Los Angeles 2
Minturno 2
Mirabella Eclano 2
Montereale Valcellina 2
Mountain View 2
Nanchang 2
Ningbo 2
Padova 2
Palestrina 2
Pescara 2
Pescia 2
Pisa 2
Pozzuoli 2
Racalmuto 2
Rho 2
Rossano 2
Rovigo 2
San Giovanni Teatino 2
San Nicola la Strada 2
San Stino di Livenza 2
Scafati 2
Sestu 2
Trieste 2
Turin 2
Venice 2
Vigevano 2
Washington 2
Wettingen 2
Agrigento 1
Amsterdam 1
Borås 1
Brno 1
Cameri 1
Totale 978
Nome #
Analisi delle sottopopolazioni linfocitarie nel trattamento cortisonico 438
Antibodies against food antigens in patients with autistic spectrum disorders. 133
A PILOT STUDY ON LOW-DOSE INTRAVENOUS CICLOPHOSPHAMIDE IN SYSTEMIC SCLEROSIS: EFFICACY, SAFETY AND EFFECTS ON CELLULAR ACTIVATION MARKERS 106
CROSSLINKS PIRIDINICI URINARI IN PAZIENTI AFFETTI DA SCLEROSI SISTEMICA 103
Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma 86
Nuove tecnologie CDR (Component Resolved Diagnosis) nell’iter diagnostico di lavoratori ipersuscettibili esposti al lattice: stratificazione del rischio e gestione del giudizio di idoneità 83
Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. 80
ESCREZIONE URINARIA DI PIRIDINOLINE IN PAZIENTI DI SCLEROSI SISTEMICA E LUPUS ERITEMATOSO SISTEMICO 78
CROSSLINKS DEL COLLAGENE NELLE URINE DI PAZIENTI SCLERODERMICI: RISULTATI PRELIMINARI 76
Behavior of sICAM-1 and sELAM-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma 75
CLINICAL AND SUBCLINICAL ATHEROSCLEROSIS IN SYSTEMIC SCLEROSIS (SSC) PATIENTS 71
Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience 67
Evidence for bone resorption in systemic sclerosis 66
INCREASED LEVES OF URINARY PYRIDINIUM CROSSLINKS OF COLLAGEN IN SYSTEMIC SCLEROSIS. 63
Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI) 39
Sensitization to nsLTP: A Retrospective Study in An Italian Pediatric Population over the Last Decade 21
Totale 1.585
Categoria #
all - tutte 5.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202084 0 0 0 0 16 6 17 9 13 3 14 6
2020/2021176 16 4 19 11 28 2 21 20 3 32 15 5
2021/2022153 13 1 5 15 34 4 3 5 3 16 10 44
2022/2023359 40 10 13 12 42 24 2 40 152 8 4 12
2023/2024296 26 27 19 30 49 31 22 9 12 13 21 37
2024/2025177 11 26 23 47 70 0 0 0 0 0 0 0
Totale 1.585